Abdominal pain is a common symptom encountered in clinical practice, with its etiology ranging from benign to life-threatening conditions. Its assessment can be challenging due to the broad differential diagnosis and the complex nature of the abdominal anatomy. This article aims to provide a comprehensive approach to evaluating abdominal pain in clinical practice.
The initial assessment should involve a thorough history taking and physical examination. The nature, onset, duration, location, and radiation of pain, associated symptoms, and exacerbating or relieving factors should be meticulously noted. The physical examination should focus on inspecting, palpating, percussing, and auscultating the abdomen.
Investigations should be guided by the clinical suspicion. Basic investigations like complete blood count, liver function tests, renal function tests, and urinalysis are usually ordered. Imaging studies like ultrasound, CT scan, or MRI may be needed based on the clinical scenario. In some cases, endoscopic procedures may be warranted.
Management is directed towards the underlying cause. It may range from conservative measures like dietary modifications and medications to surgical interventions. In some cases, a multidisciplinary approach involving gastroenterologists, surgeons, radiologists, and pain management specialists may be required.
Follow-up is crucial in patients with abdominal pain. It helps to assess the response to treatment, monitor for complications, and reassess the diagnosis if the patient is not improving. It also provides an opportunity to address the patient's concerns and expectations.
Evaluating abdominal pain requires a systematic approach involving a thorough history, physical examination, appropriate investigations, and targeted management. Regular follow-up is essential to ensure optimal patient outcomes. By adopting such a comprehensive approach, clinicians can effectively decipher the enigma of abdominal pain in their daily practice.
1.
Research discovery halts childhood brain tumor before it forms
2.
Increased Data Support Active Monitoring for Low-Risk Prostate Cancer.
3.
'CDC Must Be Investigated'; David Lynch, Bob Uecker Die; Nasal Epinephrine Warning
4.
Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.
5.
Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers
1.
Beyond the Blinders: A Review of Targeted Therapeutic Strategies for Triple-Negative Breast Cancer in 2025
2.
AI-Based Cancer Follow-Up Monitoring: Transforming Survivorship Care through Intelligent Surveillance
3.
Preventing Sarcopenia During Cancer Treatment
4.
Guidance for Managing Complex Anticoagulation
5.
Unlocking the Potential of Sarclisa: A New Hope for Cancer Treatment
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on Standard V/S High Risk Myeloma Treatment
2.
Navigating the Complexities of Ph Negative ALL - Part XIV
3.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
4.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation